Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
NVIDIA
NVDA
|
$389M |
| 2 |
Boeing
BA
|
$376M |
| 3 |
Bank of America
BAC
|
$334M |
| 4 |
UnitedHealth
UNH
|
$330M |
| 5 |
Union Pacific
UNP
|
$280M |
Top Sells
| 1 |
CSX Corp
CSX
|
$554M |
| 2 |
Home Depot
HD
|
$344M |
| 3 |
Apple
AAPL
|
$342M |
| 4 |
Adobe
ADBE
|
$301M |
| 5 |
ATVI
Activision Blizzard Inc.
ATVI
|
$286M |
Sector Composition
| 1 | Technology | 23.78% |
| 2 | Healthcare | 15.26% |
| 3 | Financials | 14.17% |
| 4 | Industrials | 12.87% |
| 5 | Consumer Discretionary | 11.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Vertex Pharmaceuticals
VRTX
$101B
| $138M | 0.08% |
814,787
-37,454
| -4% | -$6.37M |
|
|
DPLO
302
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $138M | 0.08% |
5,385,168
+1,265,271
| +31% | +$32.3M |
|
303
Guidewire Software
GWRE
$22B
| $137M | 0.08% |
1,539,183
-78,303
| -5% | -$6.95M |
|
304
Marathon Petroleum
MPC
$54.5B
| $136M | 0.08% |
1,943,169
+858,626
| +79% | +$60.2M |
|
305
Newmont
NEM
$83.4B
| $136M | 0.08% |
3,598,606
+228,782
| +7% | +$8.63M |
|
306
PVH
PVH
$4.11B
| $136M | 0.08% |
905,694
+364,759
| +67% | +$54.6M |
|
307
Globe Life
GL
$11.3B
| $136M | 0.08% |
1,665,501
-64,617
| -4% | -$5.26M |
|
308
Pultegroup
PHM
$27.7B
| $135M | 0.08% |
4,711,816
+260,199
| +6% | +$7.48M |
|
309
MarketAxess Holdings
MKTX
$6.94B
| $135M | 0.08% |
680,335
+14,096
| +2% | +$2.79M |
|
310
IAC Inc
IAC
$2.92B
| $134M | 0.08% |
4,927,970
+1,567,452
| +47% | +$42.7M |
|
|
ALXN
311
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $132M | 0.08% |
1,061,389
-140,040
| -12% | -$17.4M |
|
312
Brown-Forman Class B
BF.B
$13.1B
| $132M | 0.08% |
2,686,024
+1,834,670
| +216% | +$89.9M |
|
313
Walt Disney
DIS
$212B
| $132M | 0.08% |
1,254,485
-2,466,685
| -66% | -$259M |
|
314
Scotiabank
BNS
$78.7B
| $131M | 0.07% |
2,322,082
+76,687
| +3% | +$4.34M |
|
315
Protolabs
PRLB
$1.19B
| $131M | 0.07% |
1,103,727
+11,783
| +1% | +$1.4M |
|
316
Nordson
NDSN
$12.7B
| $131M | 0.07% |
1,021,793
+43,471
| +4% | +$5.58M |
|
317
IPG Photonics
IPGP
$3.52B
| $131M | 0.07% |
593,969
+191,959
| +48% | +$42.4M |
|
|
BHVN
318
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $130M | 0.07% |
3,299,300
-96,830
| -3% | -$3.83M |
|
319
eBay
EBAY
$42.4B
| $130M | 0.07% |
3,593,029
+24,297
| +0.7% | +$881K |
|
320
Kohl's
KSS
$1.81B
| $130M | 0.07% |
1,786,420
+1,245,073
| +230% | +$90.8M |
|
321
VeriSign
VRSN
$26.5B
| $130M | 0.07% |
947,061
+7,063
| +0.8% | +$971K |
|
322
Trip.com Group
TCOM
$47.2B
| $129M | 0.07% |
2,713,491
-4,181,205
| -61% | -$199M |
|
323
Compañía de Cervecerías Unidas
CCU
$2.22B
| $129M | 0.07% |
5,170,602
+108,456
| +2% | +$2.71M |
|
324
Liberty Broadband Class C
LBRDK
$8.59B
| $129M | 0.07% |
1,702,477
+1,637,104
| +2,504% | +$124M |
|
|
DCP
325
DELISTED
DCP Midstream, LP
DCP
| $129M | 0.07% |
3,252,504
-91,499
| -3% | -$3.62M |
|